Sign in

CIK 0000310158

  • Large accelerated filer

Merck & Co., Inc.

Sign in to watch
Ticker
MRK
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
EIN
221918501
Phone
+1 908-740-4000
Business address
126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
Former names
Merck & Co. Inc., SCHERING PLOUGH CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$8,611,875
in 1 filing

Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. DeLuca Richard R. −$8.6M EVP&Pres, Merck Animal Heallth sold 34% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-11-04 DeLuca Richard R. EVP&Pres, Merck Animal Heallth Option exercise · Stock Option (Right to Buy) −29,782 59,564
2021-11-04 Litchfield Caroline EVP & CFO Option exercise +22,683 42,448.77
2021-11-04 Litchfield Caroline EVP & CFO Sale −18,335 $91.00 $1.7M 24,113.77
2021-11-04 Litchfield Caroline EVP & CFO Option exercise · Stock Option (Right to Buy) −22,683 0
2021-11-03 Karachun Rita A Sr. VP Fince-Global Controller Option exercise +25,000 60,798.97
2021-11-03 Karachun Rita A Sr. VP Fince-Global Controller Sale −25,000 $88.45 $2.2M 35,798.97
2021-11-03 Karachun Rita A Sr. VP Fince-Global Controller Option exercise · Stock Option (Right to Buy) −25,000 16,997
2021-11-01 Gerberding Julie L. EVP, Chief Patient Officer Option exercise +35,287 74,449.14
2021-11-01 Gerberding Julie L. EVP, Chief Patient Officer Option exercise +30,175 104,624.14
2021-11-01 Gerberding Julie L. EVP, Chief Patient Officer Option exercise +19,394 124,018.14
2021-11-01 Gerberding Julie L. EVP, Chief Patient Officer Option exercise +11,414 135,432.14
2021-11-01 Gerberding Julie L. EVP, Chief Patient Officer Sale −96,270 $87.91 $8.5M 39,162.14
2021-11-01 Gerberding Julie L. EVP, Chief Patient Officer Option exercise · Stock Option (Right to Buy) −35,287 0
2021-11-01 Gerberding Julie L. EVP, Chief Patient Officer Option exercise · Stock Option (Right to Buy) −30,175 0
2021-11-01 Gerberding Julie L. EVP, Chief Patient Officer Option exercise · Stock Option (Right to Buy) −19,394 9,698
2021-11-01 Gerberding Julie L. EVP, Chief Patient Officer Option exercise · Stock Option (Right to Buy) −11,414 22,831
2021-11-01 Clyburn Frank EVP & Pres ? Human Health Option exercise +19,915 117,010.09
2021-11-01 Clyburn Frank EVP & Pres ? Human Health Option exercise +19,847 136,857.09
2021-11-01 Clyburn Frank EVP & Pres ? Human Health Sale −39,762 $87.87 $3.5M 97,095.09
2021-11-01 Clyburn Frank EVP & Pres ? Human Health Option exercise · Stock Option (Right to Buy) −19,915 0

Page 40 of 42 · 823 trades